MedPath

An Audit of the Impact of Tailored Information Delivered Via a Digital Learning Platform

Not Applicable
Terminated
Conditions
Diabetes Mellitus, Type 1
Diabetes Mellitus, Type 2
Interventions
Behavioral: training in optimal insulin injection technique
Registration Number
NCT04007003
Lead Sponsor
Becton, Dickinson and Company
Brief Summary

The study intends to audit the impact of optimal insulin injection technique on clinical parameters and self-care behaviour of insulin treated diabetes patients in a prospective manner with a follow-up of 6 months. The optimal injection technique is delivered through education via a multimodal tailored approach augmented with a digital 'tailorable' patient learning platform .

The study is conducted in multiple sites across Belgium. Diabetes patients with or without lipohypertrophy will be entered into the audit. The end points will include the impact on use of insulin, long term blood glucose control (HbA1c), hypoglycaemia, glucose variability, needle reuse, patient injection habits and clinician education, training and information inputs.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
170
Inclusion Criteria
  • Type 1 Diabetes Mellitus, or Type 2 Diabetes Mellitus
  • Injecting insulin for at least 1 year
  • Self-managing injection therapy, including daily glucose monitoring
  • Access to a device with internet
  • Confident in navigating the internet
Read More
Exclusion Criteria
  • Pregnant or likely to become pregnant during study period
  • Impaired cognitive ability which would prevent informed consent
  • Syringe only user
  • Insulin pump user
  • Glucagon-Like Peptide (GLP)-1 receptor agonists therapy only
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
optimal injection techniquetraining in optimal insulin injection techniqueSubjects will be trained on site regarding optimal insulin injection technique, including avoiding injections in lipohypertrophy areas and proper rotation. Furthermore subjects are provided with access codes to watch online training modules on the Becton Dickinson (BD) and Me(TM) platform
Primary Outcome Measures
NameTimeMethod
Change in Insulin Useup to 6 months

Change in Total Daily Dose of insulin for subjects at baseline and after 6 months; expressed as % and units/24 hrs

Secondary Outcome Measures
NameTimeMethod
Change in Needle Re-Useup to 6 months

Rate of needle re-use by self-reporting at baseline and after 6 months

Change in Glycemic Controlup to 6 months

Change in HbA1c for subjects at baseline and after 6 months; expressed as % and mmol/mol

Incidence of Hypoglycemic Eventsup to 6 months

Rate of hypoglycemic events requiring 3rd party assistance in 6 months prior to study start (baseline) and during the 6 months of the study

Trial Locations

Locations (9)

Universitair Ziekenhuis Antwerpen

🇧🇪

Antwerpen, Belgium

Imeldaziekenhuis

🇧🇪

Bonheiden, Belgium

Universitair Ziekenhuis Brussel

🇧🇪

Brussel, Belgium

Virga Jesse Ziekenhuis

🇧🇪

Hasselt, Belgium

AZ Turnhout

🇧🇪

Turnhout, Belgium

UZ Gent

🇧🇪

Gent, Belgium

AZ Groeninge

🇧🇪

Kortrijk, Belgium

AZ Nikolaas

🇧🇪

Sint-Niklaas, Belgium

AZ Jan Portaels

🇧🇪

Vilvoorde, Belgium

© Copyright 2025. All Rights Reserved by MedPath